Jiuzhou Pharma 2024 Advanced Employee Symposium Successfully Held

On March 25, Jiuzhou Pharma successfully hosted the 2024 Advanced Employee Symposium.

2025-03-31

Jiuzhou Pharma Achieves EcoVadis Gold Rating – A Testament to Our Commitment to Sustainable and Ethical CDMO Excellence

Jiuzhou Pharma is proud to announce that we have been awarded the prestigious Gold Medal in the 2024 EcoVadis Sustainability Assessment, a recognition that places us among the top 5% of companies globally for our exceptional performance in Environmental Stewardship, Labor & Human Rights, Business Ethics, and Sustainable Procurement.

2025-03-07

Jiu Zhou Pharmaceutical March Market Activity Preview

Jiu Zhou Pharmaceutical March Market Activity Preview

2025-03-05

Jiuzhou Pharma has successfully completed the UN Global Compact's SDG Ambition Accelerator (2024)

In recent days, the United Nations Global Compact (UNGC) Liaison Office in China held the 2024-2025 Corporate Accelerator Program Annual Meeting in Beijing.

2025-01-17

Jiuzhou Pharma First Selected into the FTSE4Good Index Series

Recently, FTSE Russell (the trading name of FTSE International Limited and Frank Russell Company) confirms that Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

2024-07-15

Jiuzhou Pharmaceutical has joined the United Nations Global Compact, proactively advancing sustainable development.

Recently, Jiuzhou Pharmaceutical has officially joined the United Nations Global Compact (UNGC)

2024-07-08

< 123 >

Business Collaboration

Innovative Drug CDMO Services

Established Business Services

Human Resources

Join Us

Jiuzhou

LinkedIn

License

Powered by 300.cn